61 related articles for article (PubMed ID: 22426925)
1. Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases.
Ogiwara H; Kalakota K; Rakhra SS; Helenowski IB; Marymont MH; Kalapurakal JA; Mehta MP; Levy RB; Chandler JP
J Neurooncol; 2012 May; 108(1):141-6. PubMed ID: 22426925
[TBL] [Abstract][Full Text] [Related]
2. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis.
Jensen CA; Chan MD; McCoy TP; Bourland JD; deGuzman AF; Ellis TL; Ekstrand KE; McMullen KP; Munley MT; Shaw EG; Urbanic JJ; Tatter SB
J Neurosurg; 2011 Jun; 114(6):1585-91. PubMed ID: 21166567
[TBL] [Abstract][Full Text] [Related]
3. Tumor bed radiosurgery following resection and prior stereotactic radiosurgery for locally persistent brain metastasis.
Holt DE; Gill BS; Clump DA; Leeman JE; Burton SA; Amankulor NM; Engh JA; Heron DE
Front Oncol; 2015; 5():84. PubMed ID: 25905042
[TBL] [Abstract][Full Text] [Related]
4. Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
Ko MK; Kwak YK; Choi BO; Jeun SS; Park JS; Ahn S; Song JH
J Neurooncol; 2023 Nov; 165(2):321-328. PubMed ID: 37964132
[TBL] [Abstract][Full Text] [Related]
5. Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases.
Combs SE; Bilger A; Diehl C; Bretzinger E; Lorenz H; Oehlke O; Specht HM; Kirstein A; Grosu AL
Cancer Med; 2018 Jun; 7(6):2319-2327. PubMed ID: 29696815
[TBL] [Abstract][Full Text] [Related]
6. Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
Chen WC; Lafreniere M; Phuong C; Liu SJ; Baal JD; Lometti M; Morin O; Ziemer B; Vasudevan HN; Lucas CG; Hervey-Jumper SL; Theodosopoulos PV; Magill ST; Fogh S; Nakamura JL; Boreta L; Sneed PK; McDermott MW; Raleigh DR; Braunstein SE
J Neurosurg; 2022 Oct; 137(4):924-930. PubMed ID: 35061986
[TBL] [Abstract][Full Text] [Related]
7. Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection.
Suppree JS; Kannan S; Hughes DM; Jenkinson MD; Zakaria R
Clin Exp Metastasis; 2024 Apr; 41(2):155-157. PubMed ID: 38353933
[TBL] [Abstract][Full Text] [Related]
8. Salvage pemetrexed for brain metastases from ALK-positive lung cancer after Gamma Knife radiosurgery: illustrative case.
Noda R; Akabane A; Kawashima M; Segawa M; Tsunoda S; Inoue T
J Neurosurg Case Lessons; 2024 Mar; 7(11):. PubMed ID: 38467041
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in 20 Gynecologic Cancer Patient with Brain Metastasis: A Single Institution Retrospective Study.
Kim SB; Hwang K; Joo JD; Han JH; Kim YB; Kim CY
Brain Tumor Res Treat; 2017 Oct; 5(2):87-93. PubMed ID: 29188209
[TBL] [Abstract][Full Text] [Related]
10. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Radiosurgery to Prevent Local Recurrence of Brain Metastasis After Surgery: Neoadjuvant Versus Adjuvant.
McCutcheon IE
Acta Neurochir Suppl; 2021; 128():85-100. PubMed ID: 34191064
[TBL] [Abstract][Full Text] [Related]
12. Local failure after stereotactic radiosurgery (SRS) for intracranial metastasis: analysis from a cooperative, prospective national registry.
Asher AL; Alvi MA; Bydon M; Pouratian N; Warnick RE; McInerney J; Grills IS; Sheehan J
J Neurooncol; 2021 Apr; 152(2):299-311. PubMed ID: 33481148
[TBL] [Abstract][Full Text] [Related]
13. A Dose-Response Model of Local Tumor Control Probability After Stereotactic Radiosurgery for Brain Metastases Resection Cavities.
Gui C; Grimm J; Kleinberg LR; Zaki P; Spoleti N; Mukherjee D; Bettegowda C; Lim M; Redmond KJ
Adv Radiat Oncol; 2020; 5(5):840-849. PubMed ID: 33083646
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases.
Martinage G; Geffrelot J; Stefan D; Bogart E; Rault E; Reyns N; Emery E; Makhloufi-Martinage S; Mouttet-Audouard R; Basson L; Mirabel X; Lartigau E; Pasquier D
Front Oncol; 2019; 9():184. PubMed ID: 30984617
[No Abstract] [Full Text] [Related]
15. Postoperative Cavity Stereotactic Radiosurgery for Brain Metastases.
Marchan EM; Peterson J; Sio TT; Chaichana KL; Harrell AC; Ruiz-Garcia H; Mahajan A; Brown PD; Trifiletti DM
Front Oncol; 2018; 8():342. PubMed ID: 30234013
[TBL] [Abstract][Full Text] [Related]
16. Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection.
Bilger A; Bretzinger E; Fennell J; Nieder C; Lorenz H; Oehlke O; Grosu AL; Specht HM; Combs SE
Cancer Med; 2018 Jun; 7(6):2350-2359. PubMed ID: 29745035
[TBL] [Abstract][Full Text] [Related]
17. Resection cavity radiosurgery for intracranial metastases: a review of the literature.
Zhang Y; Chang EL
J Radiosurg SBRT; 2014; 3(2):91-102. PubMed ID: 29296390
[TBL] [Abstract][Full Text] [Related]
18. HFSRT of the resection cavity in patients with brain metastases.
Specht HM; Kessel KA; Oechsner M; Meyer B; Zimmer C; Combs SE
Strahlenther Onkol; 2016 Jun; 192(6):368-76. PubMed ID: 26964777
[TBL] [Abstract][Full Text] [Related]
19. Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases.
Vogel J; Ojerholm E; Hollander A; Briola C; Mooij R; Bieda M; Kolker J; Nagda S; Geiger G; Dorsey J; Lustig R; O'Rourke DM; Brem S; Lee J; Alonso-Basanta M
Radiat Oncol; 2015 Oct; 10():221. PubMed ID: 26520568
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
